Suchbegriffe: PRASUGREL HYDROCHLORIDE - THERAPEUTIC USE , . Treffer: 2
Winter, MP; von Lewinski, D; Wallner, M; Prüller, F; Kolesnik, E; Hengstenberg, C; Siller-Matula, JM
Incidence, predictors, and prognosis of premature discontinuation or switch of prasugrel or ticagrelor: the ATLANTIS - SWITCH study.
Sci Rep. 2019; 9(1):8194-8194
Doi: 10.1038/s41598-019-44673-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tscharre, M; Egger, F; Machata, M; Rohla, M; Michael, N; Neumayr, M; Zweiker, R; Hajos, J; Adlbrecht, C; Suppan, M; Helmreich, W; Eber, B; Huber, K; Weiss, TW
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
PLoS One. 2017; 12(6):e0179349-e0179349
Doi: 10.1371/journal.pone.0179349
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG